Information  X 
Enter a valid email address

GSK PLC Ord 31 1/4P (GSK)

Date Time Source Announcement
17 Aug 2022 7:00 am
RNS
FDA New Drug Application File Acceptance for MMB
  7:00 am
RNS
Statement: Zantac (ranitidine) litigation update
16 Aug 2022 7:06 am
RNS
GSK completes acquisition of Affinivax, Inc.
12 Aug 2022 7:00 am
RNS
Statement: Zantac (ranitidine) litigation
11 Aug 2022 11:51 am
RNS
Director/PDMR Shareholding
10 Aug 2022 4:57 pm
RNS
Director/PDMR Shareholding
01 Aug 2022 6:10 pm
RNS
Total Voting Rights
  1:43 pm
RNS
Director/PDMR Shareholding
29 Jul 2022 2:00 pm
RNS
Director/PDMR Shareholding
  10:00 am
RNS
GSK Board change
28 Jul 2022 1:01 pm
RNS
Director/PDMR Shareholding
27 Jul 2022 7:00 am
RNS
2nd Quarter Results
26 Jul 2022 5:35 pm
RNS
Holding(s) in Company
22 Jul 2022 4:45 pm
RNS
Holding(s) in Company
  4:17 pm
RNS
Board and Committee Changes
19 Jul 2022 7:00 am
RNS
Completion of GSK Share Consolidation
18 Jul 2022 6:00 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Haleon demerger completion and share consolidation
12 Jul 2022 9:48 am
RNS
Director/PDMR Shareholding
11 Jul 2022 5:30 pm
RNS
GSK
08 Jul 2022 6:04 pm
RNS
Director/PDMR Shareholding
  5:30 pm
RNS
Director/PDMR Shareholding
  3:53 pm
RNS
Director/PDMR Shareholding
  3:33 pm
RNS
Director/PDMR Shareholding
  3:10 pm
RNS
Director/PDMR Shareholding
06 Jul 2022 4:30 pm
RNS
Result of General Meeting
  10:11 am
RNS
Director/PDMR Shareholding
05 Jul 2022 12:43 pm
RNS
GSK disclose discontinued operations from Q2 2022
  9:45 am
RNS
Director/PDMR Shareholding
  9:30 am
RNS
Director/PDMR Shareholding
01 Jul 2022 3:27 pm
RNS
Total Voting Rights
  2:45 pm
RNS
GSK completes acquisition of Sierra Oncology
28 Jun 2022 5:56 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
GSK files Shingrix 18+ at risk indication in Japan
27 Jun 2022 4:08 pm
RNS
Director/PDMR Shareholding
24 Jun 2022 3:44 pm
RNS
Director/PDMR Shareholding
16 Jun 2022 10:58 am
RNS
Director/PDMR Shareholding
10 Jun 2022 7:00 am
RNS
Positive phase III data for GSK's RSV OA vaccine
09 Jun 2022 4:28 pm
RNS
Director/PDMR Shareholding
07 Jun 2022 5:17 pm
RNS
Director/PDMR Shareholding
  12:00 pm
EQS
Hardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis
06 Jun 2022 7:00 am
RNS
US FDA approval of Priorix
01 Jun 2022 4:55 pm
RNS
Total Voting Rights
  1:00 pm
RNS
Demerger update: Publication of Documents
  7:00 am
RNS
Demerger update: Submission of Documents to FCA
31 May 2022 7:00 am
RNS
GSK to acquire Affinivax, Inc.
30 May 2022 10:00 am
RNS
Further appointments to Designate Haleon Board
27 May 2022 7:00 am
RNS
GSK Cervarix two-dose schedule approved by NMPA
25 May 2022 3:41 pm
PRN
Director/PDMR Shareholding
23 May 2022 3:21 pm
RNS
Director/PDMR Shareholding
19 May 2022 10:02 am
RNS
Iain Mackay - External Appointment
16 May 2022 2:00 pm
RNS
Change of name to GSK plc
13 May 2022 5:13 pm
RNS
Director/PDMR Shareholding
12 May 2022 8:58 am
RNS
Director/PDMR Shareholding
11 May 2022 5:17 pm
RNS
Block listing Interim Review
09 May 2022 2:53 pm
RNS
Director/PDMR Shareholding
04 May 2022 5:49 pm
RNS
Result of AGM
  10:00 am
RNS
Directorate Change
03 May 2022 4:52 pm
RNS
Total Voting Rights
27 Apr 2022 7:00 am
RNS
1st Quarter Results

a d v e r t i s e m e n t